Non-Antibody Products — page 1 of 29,104



Non-Antibody Products
Page 1 of 29,104
  • Records 1 - 75 of 2,182,728
Name Description Size Catalog # Supplier
A 205804 Purity ≥98%. MW: 300.39 100 mg, 500 mg MBS132392 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 66 Purity ≥98%. MW: 393.52 100 mg, 500 mg MBS132169 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 740003 Purity ≥98%. MW: 474.565 100 mg, 500 mg MBS132187 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 740003 Purity >98%. A 740003 is a novel competitive antagonist of P2X7 receptors… 10 mg, 25 mg, 50 mg MBS384091 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 769662 Purity ≥98%. MW: 360.39 100 mg, 500 mg MBS130892 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 769662 Purity 97%+. MW: 360.39 5 mg, 1ml/10mM (in DMSO), 10 mg MBS576261 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 803467 Purity >98%. A 803467 is a selective blocker of NaV1.8 channels (IC50 valu… 10 mg, 1 mL (in DMSO), 25 mg MBS384093 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 83-01 Purity ≥98% by HPLC. Background: A selective inhibitor of TGF-beta type… 1 mg MBS842636 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 83-01 Purity ≥98%. MW: 421.52 100 mg, 500 mg MBS132328 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 83-01 Purity >98%. A83-01 is a TGF-β kinase / activin receptor like kinase… 5 mg, 10 mg, 25 mg MBS384095 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 922500 MW: 428.48 5 mg MBS8506458 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 922500 Purity ≥98%. MW: 428.488 100 mg, 500 mg MBS130245 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A 967079 Purity >98%. A 967079 is a selective TRPA1 channel blocker (IC50 values ar… 10 mg, 25 mg, 50 mg MBS384097 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-1155463 Purity >98%. A-1155463 is a highly potent and selective BCL-XL inhibitor,… 5 mg, 10 mg, 50 mg MBS384082 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-1210477 Purity ≥98%. MW: 886.51 100 mg, 500 mg MBS131280 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-1210477 Purity ≥99%. MW: 850.04 2 mg, 5 mg, 10 mg MBS575263 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-1210477 Purity >98%. A-1210477 is a potent and selective MCL-1 inhibitor. A-121047… 5 mg, 10 mg, 25 mg MBS384084 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-1331852 Purity ≥98%. MW: 658.82 100 mg, 500 mg MBS131656 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-196 Purity ≥99%. A-196 is a potent and selective inhibitor of SUV420 h1 and… 2 mg, 1ml/10mM (in DMSO), 5 mg MBS5750478 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-205804 Purity 97%+. MW: 300.41 5 mg, 10 mg, 1ml/10mM (in DMSO) MBS576130 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A23187 Purity >98% by TLC. Background: A calcium ionophore. Causes rapid influx o… 10 mg MBS843148 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-366 Purity ≥98% by HPLC. Background: A-366 is a potent and selective G9a /… 1 mg, 5 mg MBS842453 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-366 Purity ≥98%. MW: 329.444 100 mg, 500 mg MBS131198 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-366 Purity >98%. A-366 is a potent and selective G9a / GLP histone lysine meth… 10 mg, 25 mg, 50 mg MBS384085 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A427 A427 cells are derived from human lung epithelial carcinoma taken from a 5… 0.1 mg, 0.2 mg, 0.5 mg MBS201043 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A431 A431 cells were established from an epidermoid carcinoma in the skin / epi… 0.1 mg, 0.2 mg, 0.5 mg MBS201022 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-443654 Purity >98%. A-443654, a specific Akt inhibitor with Ki value of 160 pM, i… 2 mg, 5 mg, 10 mg MBS384086 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-484954 Purity >98%. A-484954 is a potent, selective inhibitor of eukaryotic longa… 10 mg, 25 mg, 50 mg MBS384087 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A549 A549 cells are adenocarcinomic human alveolar basal epithelial cells. The… 0.1 mg, 0.2 mg, 0.5 mg MBS201023 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A66 MW: 393.53 10 mg MBS8506193 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A66 Purity >98%. The S-enantiomer of A66 is a potent inhibitor of the p110alph… 5 mg, 1 mL (in DMSO), 10 mg MBS384089 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A66 Purity 97%+. MW: 393.53 2 mg, 5 mg, 1ml/10mM (in DMSO) MBS575616 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-674563 MW: 358.44 2 mg MBS8506244 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-674563 Purity ≥98%. A-674563 is an Akt1 inhibitor with Ki of 11 nM, modest pot… 1 mg, 2 mg, 5 mg MBS578707 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-674563 Purity ≥98%. MW: 358.445 100 mg, 500 mg MBS131746 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-674563 Purity >98%. A-674563 is a B / Akt inhibitor with an IC50 of 14 nM and als… 5 mg, 1 mL (in DMSO), 10 mg MBS384090 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-769662 Purity ≥98% by HPLC. Background: Cell-permeable. A potent AMPK activato… 5 mg MBS842018 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-769662 Purity >98%. A-769662 is a new activator of AMP-activated protein kinase (… 5 mg, 10 mg, 1 mL (in DMSO) MBS384092 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A77 1726 Purity ≥98% by HPLC. Background: Physiologically active metabolite of t… 5 mg, 25 mg MBS842963 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A77-01 Purity ≥98%. MW: 286.33 2 mg, 5 mg, 1ml/10mM (in DMSO) MBS577536 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A77-01 Purity ≥98%. MW: 286.338 100 mg, 500 mg MBS130865 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-803467 Purity ≥98% (TLC). MW: 357.8 10 mg, 50 mg MBS565381 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-803467 Purity ≥98% by TLC. Background: A-803467 is a potent, selective inhibit… 5 mg, 25 mg MBS842200 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-803467 Purity ≥98%. MW: 357.79 100 mg, 500 mg MBS132100 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-803467 Purity ≥98%. MW: 357.79 1ml/10mM (in DMSO), 10 mg, 25 mg MBS575739 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-804598 Purity >98%. A-804598 is a P2X7 selective, competitive antagonist with the… 5 mg, 10 mg, 25 mg MBS384094 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A83-01 Purity >98% (TLC); NMR (Conforms). ALK inhibitor. Selective glycogen synth… 5 mg, 25 mg MBS515040 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-83-01 Purity 97%+. MW: 421.52 2 mg, 5 mg, 10 mg MBS575483 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-966492 A-966492 is a highly potent and efficacious poly(ADP-ribose) polymerase (P… 10 mg MBS8506196 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-966492 Purity ≥98%. A-966492 is a novel and potent inhibitor of PARP1 and PARP… 2 mg, 5 mg, 1ml/10mM (in DMSO) MBS578914 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-966492 Purity ≥98%. MW: 324.359 100 mg, 500 mg MBS132689 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
A-966492 Purity >98%. A-966492 displayed high potency against the poly(ADP-ribose)… 5 mg, 1 mL (in DMSO), 10 mg MBS384096 MYBIOSOURCE INC.
MYBIOSOURCE INC.
More Info
293A The HEK 293A cell line is an immortalized line of primary human embryonic… 1 vial ABI-TC1333 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A10.7 Species: human. Derived from metastatic liver tumor (clinical stage IV). 1 vial ABC-TC533S ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A-172 Species: human. Organ: brain Disease: glioblastoma. 1 vial ABC-TC0022 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A-204 Human Muscle Rhabdomyosarcoma cell line. The A-204 cell line was establish… 1 vial ABC-TC445S ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A2058 Species: human. Malignant melanoma, metastasis to lymph node. 1 vial ABC-TC0023 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A-253 The A253 line is one of thirteen to be isolated and partially characterize… 1 vial ABC-TC0024 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A375 Species: human. This line was derived from a 54 year old female with malig… 1 vial ABC-TC0026 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A-427 Species: human. A-427 cell line was established from the lung carcinoma of… 1 vial ABC-TC1339 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A-431 Species: human. The epidermoid carcinoma cell line A-431, derived from an… 1 vial ABC-TC0030 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A-498 Species: human. Established from the kidney carcinoma of a 52-year-old man… 1 vial ABC-TC0031 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A549 Species: human. A549 cell line was initiated in 1972 by D.J. Giard, et al.… 1 vial ABC-TC0032 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A6 Frog (Xenopus laevis) cell line derived from kidney. Lifespan: infinite. 1 vial ABC-TC020S ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A-673 Species: human. Tissue: muscle Disease: rhabdomyosarcoma. 1 vial ABC-TC0034 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A-704 Human kidney adenocarcinoma. Derived from 78-year-old male. Does not produ… 1 vial ABC-TC0021 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A-72 Canine Golden Retriever tumour. Derived from tumour of thigh (unknown hist… 1 vial ABC-TC0036 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A9 Mouse C3H / An areolar and adipose tissue. Derivative of L929 selected in… 1 vial ABC-TC0037 ACCEGEN BIOTECH
ACCEGEN BIOTECH
More Info
A1120 n/a n/a A3111 MILLIPORE-SIGMA
MILLIPORE-SIGMA
More Info
A-196 A-196 is a small molecule which can act as a Selective inhibitor of lysine… 5 mg, 25 mg abx282942 ABBEXA LTD
ABBEXA LTD
More Info
A-23187 A-23187 is a small molecule which can act as a Ca2+ ionophore. It is provi… 5 mg, 25 mg abx076596 ABBEXA LTD
ABBEXA LTD
More Info
A-769662 A-769662 is a small molecule which can act as an AMPK activator. It is pro… 5 mg, 25 mg abx076760 ABBEXA LTD
ABBEXA LTD
More Info
A77 1726 A77 1726 is a small molecule which can act as a DHODH inhibitor. It is pro… 5 mg, 25 mg abx282325 ABBEXA LTD
ABBEXA LTD
More Info
A-803467 A-803467 is a small molecule which can act as a Sodium NaV1.8 channel bloc… 10 mg, 50 mg abx076576 ABBEXA LTD
ABBEXA LTD
More Info
A83-01 A83-01 is a small molecule which can act as an ALK inhibitor. It is provid… 5 mg, 25 mg abx076740 ABBEXA LTD
ABBEXA LTD
More Info

© 1980 - 2022 Linscott's Directory, Linscott's USA. All rights reserved.